Skip to main content
. 2025 May 23;16:1541946. doi: 10.3389/fgene.2025.1541946

TABLE 2.

Related indicators of the sex hormone parameters of the four patients.

Items Patient 1 Patient 2 Patient 3 Patient 4 Clinical
Prolactin (PRL) 108 468.4 66.7 6.37 Follicular stage 66–490
Ovulation period 66–490
Luteal phase 66–490
Menopause 62–410
Follicle oietin (FSH) 5.71 4.286 0.167 11.09 Follicular stage 3.2–15
Ovulation period 7.5–20
Luteal phase 1.3–11
Menopause 36–138
Luteinizing hormone (LH) 5.98 4.764 <0.1 0.77 Follicular stage 1.2–12.5
Ovulation period 12–82
Luteal phase 0.4–19
Menopause 14–48
Progesterone 1.03 0.454 1.122 3.27 Follicular stage 0.4–2.3
Luteal phase 1.2–18.8
Menopause 0–1.4
Testosterone (TEST) 2,67 1.055 1.228 3.5 Follicular stage 0–1.0
Ovulation period 0–1.0
Luteal phase 0–1.0
Menopause 0–1.0

Note: All four patients had normal prolactin. Unit (mIU/mL). These four patients had normal FSH, LH, and progesterone. The patient 1, 2, and 3 had normal androgen and the fourth patient had elevated androgen.